Clinical Trials Update: Jan. 8, 2004
Parkinson's Disease Asthma Depression (Major/Severe)
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A research study of an investigational medication to test the effectiveness of a new formulation of a marketed drug in increasing the time to onset of dyskinesia in Parkinson's disease patients who have been taking levodopa for less than 2 years. Volunteers 30 to 70 may be eligible. Research site located in West Yarmouth, Mass.
A clinical research study for the treatment of asthma. Volunteers in good health age 18 or older who have been diagnosed with asthma and who are non-smokers or ex-smokers (more than one year tobacco free) may be eligible. Research site located in San Luis Obispo, Calif.
A study of an investigational medication for the prevention of depressive relapse in adult outpatients with major depressive disorder (MDD). Volunteers 18 to 75 who have a primary diagnosis of MDD and have had depressive symptoms for at least 30 days before entry in the study may be eligible. Research sites located throughout the United States.
Copyright 2004 CenterWatch. All rights reserved.